I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Efficacy and Tolerability of Erenumab in the Management of Persistent Redness and Flushing in Rosacea
An exploratory open-label study of rosacea patients to study the efficacy and tolerability of erenumab in the prophylactic treatment of persistent redness and flushing attributed to rosacea. Approximately 30 subjects will be included in the study and receive erenumab 140 mg for three months. The study will begin June 2020 …
headache
rosacea
flushing
erenumab
erythematotelangiectatic rosacea
- 0 views
- 19 Feb, 2024